Staining for CD4+ and CD8+ T cells revealed that both localized at the tumor/stromal interface in size-matched D2A1 tumors (Figure 3H; a feature observed in approximately 26% of TNBCs, ref. 33). The gene discussed is CD8A; the disease is neoplasm.